Literature DB >> 2437064

Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.

S Chadha, W J Honnebier, A Schaberg.   

Abstract

Two cases of Sertoli-Leydig cell tumor (SLCT) of the ovary associated with elevated serum alpha-fetoprotein (AFP) levels are described. A 16-year-old girl (case 1) had a Sertoli-Leydig cell tumor containing heterologous elements in the form of mucinous epithelium; AFP was demonstrated within the Sertoli cells by immunohistochemical techniques. An 11-month-old girl (case 2) had a SLCT with a retiform pattern and heterologous elements in the form of cells resembling hepatocytes; AFP was localized in the hepatocytes by immunohistochemical techniques.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437064     DOI: 10.1097/00004347-198703000-00010

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  Endocrine pathology of the ovary : in tribute to Robert E Scully, MD.

Authors:  Esther Oliva; Robert H Young
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 2.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

3.  Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.

Authors:  S Chadha; T H van der Kwast
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  15-Year-Old Patient with an Unusual Alpha-Fetoprotein-Producing Sertoli-Leydig Cell Tumor of Ovary.

Authors:  Kaçar Serife; Stavros Karampelas; Nathalie Hottat; Christine Devalck; Katherina Vanden Houte
Journal:  Case Rep Obstet Gynecol       Date:  2022-04-12

5.  Hormonally Functional Ovarian Neoplasms.

Authors:  Lawrence M. Roth; Steven D. Billings
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.